| Authors: |
Taylor MR; Department of Pediatrics, Division of Hematology/Oncology, University of Washington, Seattle, Washington, USA.; Ben Towne Center For Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA., Anderson JR; College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA., Park JR; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Irwin MS; Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Applebaum MA; Department of Pediatrics, University of Chicago, Chicago, Illinois, USA., Pinto NR; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA., Streby K; Department of Hematology/Oncology/BMT, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Federico SM; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Rosswog C; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany., Ohira M; Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan., Kao PC; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Cash T; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA. |
